The global drug screeningmarket was valued at USD 3.83 Billion in 2019 and is projected to reach USD13.56 Billion by 2027, at a CAGR of 17.1% during the forecast period. Upsurgein consumption of illegal substances and alcohol and implementation of stringentregulations in developing as well as developed regions are propelling the drugscreening market. The drug screening process has become quite common atairports and railway stations to ensure the safety of the local population.
The latest market study, DrugScreening Market blends in qualitative and quantitative research techniques topresent vital data on the competitive landscape for the period of 2020 - 2027.Thisresearch allows the business owners/individuals/ stakeholders to collectdecisive information about market segmentation based on product category, usageand sale volume across the various geographical regions. Business stakeholderscan prepare effective expansion plan by using the statistics on market share,size and the growth rate discussed in the report, for the forecast period of2020 - 2027.Unmatched information on past, present and upcoming market trends coveredin the study offer lucidity on the future projection of the industry.
Readmore@ https://www.emergenresearch.com/industry-report/drug-screening-market
KeyHighlights of Report
In May 2020, Psychemedics Corporation launched a vapingpanel to detect the use of nicotine, marijuana, and Cannabidiol (CBD). Thistest helps businesses and schools detect the presence of any drugs ingested byany means. It is specifically designed to combat the e-cigarette trend amongyoungsters.
Breathalyzers are used to estimate the content of alcoholfrom the breath. The product witnesses high demand as it is easy to acquire, itgives accurate results, and the test can be conducted from anywhere.
Breath samples have also been observed to offer variousadvantages for drug screening, as they are less intrusive, less invasive, andless time-consuming as compared to urine or blood samples
The workplace end-use segment held the largest market sharein 2019, as several companies observe a strict random drug test policy tomaintain a safe working environment and enhance productivity. Severalprofessional sporting events also conduct drug screening to prevent cheating.
North America held the largest share of the global drugscreening market in the year 2019. Increased incidence of drug abuse in theregion and implementation of regulations permitting drug screening are likelyto drive the market in North America during the forecast period.
Key market participants include Quest Diagnostics, LabCorp,Drägerwerk, Thermo Fisher Scientific, Alfa Scientific Designs, OmegaLaboratories, Roche Diagnostics Limited, Siemens Healthineers, Premier Biotech,and Psychemedics
You CanDownload Free Sample PDF Copy of Drug Screening Market at https://www.emergenresearch.com/request-sample/442
RegionalLandscape
North America (U.S., Canada)
Europe (U.K., Italy, Germany,France, Rest of EU)
Asia Pacific (India, Japan,China, South Korea, Australia, Rest of APAC)
Latin America (Chile, Brazil,Argentina, Rest of Latin America)
Middle East & Africa (SaudiArabia, U.A.E., South Africa, Rest of MEA)
AboutUs:
At Emergen Research, we believein advancing with technology. We are a growing market research and strategyconsulting company with an exhaustive knowledge base of cutting-edge andpotentially market-disrupting technologies that are predicted to become moreprevalent in the coming decade.
BrowseMore Research Reports
Coldstorage construction market: https://www.emergenresearch.com/industry-report/cold-storage-construction-market
TopicalDrug Delivery Market: https://www.emergenresearch.com/industry-report/topical-drug-delivery-market
QuantumComputing for Enterprise Market: https://www.emergenresearch.com/industry-report/quantum-computing-for-enterprise-market
IndustrialNitrogen Market: https://www.emergenresearch.com/industry-report/industrial-nitrogen-market
ConstructionEquipment Rental Market: https://www.emergenresearch.com/industry-report/construction-equipment-rental-market
ContactUs:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web:www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Facebook | LinkedIn | Twitter |Blogs
